Immuno 2026 Day 6 Highlights: Dose Optimization and Better Research Decisions
Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications
EVOLUTE: Enfortumab Vedotin in Older Patients With Advanced Urothelial Carcinoma
A New Era in Cervical Cancer Prevention in Algeria: Integration of HPV Vaccination into the National Immunization Program
Deulorlatinib in ALK-Positive NSCLC: Can Deuteration Improve on Lorlatinib?
Radiotherapy for R/R Hodgkin Lymphoma: Targeting Residual Disease After BV and PD-1 Blockade
Pfizer to Present 45 Abstracts at ESMO 2026, With Data in Breast, Genitourinary, Lung Cancers and Melanoma
The YS2C – Young Scientist Cancer Congress 2026 will take place from October 1–2, 2026, at the Amphitheater of IUCT-Oncopole in Toulouse, France. Organized as an international scientific meeting dedicated to early-career researchers and clinicians in cancer research, YS2C aims to foster scientific exchange, highlight emerging research, and create networking opportunities across the cancer research […]
